Skip to main content

Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*

The Original Article was published on 11 January 2019

Correction to: BMC Pharmacol Toxicol 20, 5 (2019)

https://doi.org/10.1186/s40360-018-0280-8

After publication of the original article [1], an error was identified in the Results section, with regard to values of Table 1.

The incorrect sentence is:

SIB peak plasma concentrations were 207.1 mg/L for SPC and 12.6 mg/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001).

The correct sentence is:

SIB peak plasma concentrations were 207.1 ng/L for SPC and 12.6 ng/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001).

The original article has been corrected.

Reference

  1. 1.

    Méndez-Sánchez N, et al. Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*. BMC Pharmacol Toxicol. 2019;20:5. https://doi.org/10.1186/s40360-018-0280-8.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Nahum Méndez-Sánchez.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Méndez-Sánchez, N., Dibildox-Martinez, M., Sosa-Noguera, J. et al. Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*. BMC Pharmacol Toxicol 22, 37 (2021). https://doi.org/10.1186/s40360-021-00500-2

Download citation